Positron emission tomography: measurement of transgene expression

被引:10
作者
de Vries, EFJ [1 ]
Vaalburg, W [1 ]
机构
[1] Univ Groningen Hosp, PET Ctr, NL-9700 RB Groningen, Netherlands
关键词
positron emission tomography; gene expression; HSVtk; 9-(3-[(18)Fluoro-1-hydroxy-2-hropoxy)methylguanine; gene therapy; noninvasive imaging;
D O I
10.1016/S1046-2023(02)00080-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Noninvasive and repetitive imaging of transgene expression can play a pivotal role in the development of gene therapy strategies, as it offers investigators a means to determine the effectiveness of their gene transfection protocols. In the last decade, imaging of transgene expression using positron emission tomography (PET) or single-photon emission computed tomography (SPECT) has received considerable attention and as a result several imaging methods have now been evaluated in animals. As a typical example of noninvasive imaging of transgene expression, this article describes the principles of monitoring the expression of the herpes simplex virus type I thymidine kinase gene with PET, using the ganciclovir analog 9-(3-[F-18]fluoro-1-hydroxy-2-propoxy)methylguanine as the tracer. In addition to a description of the execution of the PET scan and data analysis, the types of transgene animal models that are applied and the principal limitations of the imaging technique are summarized. Finally, several indirect approaches to image transgenes via a linked reporter gene are discussed. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 38 条
[1]   Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG):: A new potential imaging agent for viral infection and gene therapy using PET [J].
Alauddin, MM ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) :175-180
[2]   Synthesis of 9-[(3-[F-18]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]-FHPG): A potential imaging agent of viral infection and gene therapy using PET [J].
Alauddin, MM ;
Conti, PS ;
Mazza, SM ;
Hamzeh, FM ;
Lever, JR .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06) :787-792
[3]  
Alauddin MM, 2001, J NUCL MED, V42, P1682
[4]  
Balatoni J. A., 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P103
[5]   Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer [J].
Bennett, JJ ;
Tjuvajev, J ;
Johnson, P ;
Doubrovin, M ;
Akhurst, T ;
Malholtra, S ;
Hackman, T ;
Balatoni, J ;
Finn, R ;
Larson, SM ;
Federoff, H ;
Blasberg, R ;
Fong, YM .
NATURE MEDICINE, 2001, 7 (07) :859-863
[6]  
CHENG YC, 1983, J BIOL CHEM, V258, P2460
[7]  
de Vries EFJ, 2000, J NUCL MED, V41, p263P
[8]   Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo [J].
Doubrovin, M ;
Ponomarev, V ;
Beresten, T ;
Balatoni, J ;
Bornmann, W ;
Finn, R ;
Humm, J ;
Larson, S ;
Sadelain, M ;
Blasberg, R ;
Tjuvajev, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9300-9305
[9]   The road toward human gene therapy - A 25-year perspective [J].
Friedmann, T .
ANNALS OF MEDICINE, 1997, 29 (06) :575-577
[10]  
Gambhir SS, 1998, J NUCL MED, V39, P2003